美股
Lead report
BioNxt Raises CAD 2M in Private Placement to Accelerate Oral Drug Delivery Platform Development
BioNxt Solutions announces a private placement of up to CAD 2 million to advance its oral cladribine pipeline. Explore the financing details, market outlook, and investment risks for this small biotech firm.
